Verisk Analytics, Inc. Total Revenue increased by 0.5% to $782.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.9%, from $753.00M to $782.60M. Over 4 years (FY 2021 to FY 2025), Total Revenue shows relatively stable performance with a 0.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $747.50M | $759.00M | $766.00M | $775.50M | $746.30M | $745.30M | $229.90M | $651.60M | $675.00M | $677.60M | $677.20M | $704.00M | $716.80M | $725.30M | $735.60M | $753.00M | $772.60M | $768.30M | $778.80M | $782.60M |
| QoQ Change | — | +1.5% | +0.9% | +1.2% | -3.8% | -0.1% | -69.2% | +183.4% | +3.6% | +0.4% | -0.1% | +4.0% | +1.8% | +1.2% | +1.4% | +2.4% | +2.6% | -0.6% | +1.4% | +0.5% |
| YoY Change | — | — | — | — | -0.2% | -1.8% | -70.0% | -16.0% | -9.6% | -9.1% | +194.6% | +8.0% | +6.2% | +7.0% | +8.6% | +7.0% | +7.8% | +5.9% | +5.9% | +3.9% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Underwriting | $507.50M | $506.90M | $511.50M | $532.00M | $549.60M | $542.10M | $556.20M | $552.10M |
| Claims | $209.30M | $218.40M | $224.10M | $221.00M | $223.00M | $226.20M | $222.60M | $230.50M |
| Specialized Markets | $0.00 | $0.00 | $0.00 | — | — | — | — | — |
| Total | $716.80M | $725.30M | $735.60M | $753.00M | $772.60M | $768.30M | $778.80M | $782.60M |
Specialized Markets is derived from annual filings.
Specialized Markets, Underwriting And Rating were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 |
|---|---|---|---|---|---|---|---|---|
| Insurance | $651.60M | $675.00M | $677.60M | $677.20M | $704.00M | $716.80M | $725.30M | $735.60M |
| Financial Services | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | $651.60M | $675.00M | $677.60M | $677.20M | $704.00M | $716.80M | $725.30M | $735.60M |
Financial Services, Insurance were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|
| Energy And Specialized Markets | $165.90M | $22.40M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | $759.00M | $775.50M | $746.30M | $745.30M | $229.90M | $651.60M | $675.00M | $677.60M |
Energy And Specialized Markets was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| US | $593.60M | $604.10M | $607.30M | $621.50M | $627.50M | $631.90M | $641.40M | $638.40M |
| Other Countries | $72.20M | $67.90M | $70.10M | $71.50M | $82.00M | $72.70M | $74.10M | $78.90M |
| GB | $51.00M | $53.30M | $58.20M | $60.00M | $63.10M | $63.70M | $63.30M | $65.30M |
| Total | $716.80M | $725.30M | $735.60M | $753.00M | $772.60M | $768.30M | $778.80M | $782.60M |